Handrean Soran
Handrean Soran is an expert in Endocrinology at Manchester University NHS Foundation Trust (United Kingdom). As of September 2026, ScienceLeadR ranks Handrean Soran in the top 1% of experts worldwide for Dyslipidemias, Hyperlipidemias and Lipid Metabolism Disorders. Handrean Soran has authored 361 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 1,215 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Cardiology - Biochemistry - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 361
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Interrelationship Between Socioeconomic Status, Depression, and Neuropathy in People with Diabetes: A Cross-Sectional Study. PMID 42122948 — diabetes mellitus, depression, neural conduction, cross-sectional studies, signs and symptoms, prevalence | J Clin Med | 2026 | 0 |
| Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United Kingdom. PMID 40919303 — research design, genes, genetic testing, genotype, diagnosis, hyperlipoproteinemia type i, costello syndrome | Genet Med Open | 2025 | 0 |
| Statin therapy and neuropathy in type 1 diabetes: A cross-sectional study. PMID 40704492 — diabetes mellitus, cross-sectional studies, pain, perception, diabetic neuropathies, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, diabetes mellitus, type 1 | Diabetes Obes Metab | 2025 | 0 |
| Neurodegeneration in familial chylomicronemia syndrome. PMID 40683834 — lipoproteins, perception, nerve fibers, signs and symptoms, cholesterol, triglycerides, hyperlipoproteinemia type i | J Clin Lipidol | 2025 | 1 |
| Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine. PMID 39789723 — research design, laboratories, biochemistry, heart, lipoproteins, cardiovascular diseases, chemistry, clinical, lipoprotein(a) | Ann Clin Biochem | 2025 | 1 |
Clinical Studies 18
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia NCT06832371 — hyperlipoproteinemia type ii, cholesterol, ldl, cardiovascular diseases, dyslipidemias, lipid metabolism disorders, cholesterol, atherosclerosis, therapeutics, genetic diseases, inborn, hypercholesterolemia, homozygous familial hypercholesterolemia, lipids | N/A | Active not recruiting | 2024 |
LeadR Networks
Main global connection map